Investigation announced for Investors who lost money with shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY)

An investigation was announced for investors of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares over potential securities laws violations by ARS Pharmaceuticals, Inc.

Investors who purchased shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) concerning whether a series of statements by ARS Pharmaceuticals, Inc. (NASDAQ: SPRY regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Diego, CA based ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. On September 19, 2023, ARS Pharmaceuticals, Inc. announced it received from the Food and Drug Administration (FDA) a Complete Response Letter (CRL) concerning ARS' "neffy." "Neffy" is a nasally administered epinephrine dose used in cases of severe allergic reactions. The CRL indicated ARS must complete additional studies on "neffy" before the FDA can consider further the drug's approval. In particular, the FDA indicated ARS must provide data concerning repeated doses of nasal epinephrine in individuals experiencing allergic reactions.

Shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) declined from $9.27 per share on May 22, 2023, to as low as $2.55 per share on September 20, 2023.

Those who purchased shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.